Phase I Clinical Trial Manufacturing of Inactivated SARS-COV2 Vaccine
Project Description
FDA GLP/GMP manufacturing of an inactivated SARS-COV2 vaccine including inactivation, purification, fill and finish and enough product for phase I clinical Trial.
Project Information
Number:21-02558
Industry:Manufacturing and Production
This request is closed and is no longer accepting quotes.
Register or Log In
to receive alerts when similar requests open in the future.
